Clinical trial
Targeted Molecular Probe for Abdominal Aortic Aneurysm Imaging and Therapy
NCT04592991 is registered in ClinicalTrials.gov with Washington University School of Medicine as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Targeted Molecular Probe for Abdominal Aortic Aneurysm Imaging and Therapy
- Lead sponsor
- Washington University School of Medicine
- Phase
- Phase 1
- Overall status
- Terminated
- Start date
- October 7, 2020
- Completion date
- April 4, 2022
- Enrollment
- 1 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
abdominal aortic aneurysm (aaa)